Clinical Trials on Melanoma Metastatic
Total 12008 results
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
University of Texas Southwestern Medical CenterWithdrawnMelanoma | Metastatic MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)Completed
-
VicalCompletedMetastatic MelanomaUnited States
-
Hadassah Medical OrganizationUnknown
-
Western Regional Medical CenterTerminated
-
NYU Langone HealthTerminatedMetastatic MelanomaUnited States
-
The Netherlands Cancer InstituteMerck Sharp & Dohme LLCUnknownMetastatic MelanomaNetherlands
-
Hospices Civils de LyonUnknown
-
Altor BioScienceNational Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
Gemin XTerminatedMetastatic MelanomaUnited States
-
Oncolytics BiotechUniversity of TexasCompletedMetastatic MelanomaUnited States
-
SCRI Development Innovations, LLCNovartisCompletedMetastatic MelanomaUnited States
-
Medical University of ViennaTerminated
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
Cooperative Research Centre for Biomedical Imaging...Unknown
-
Pain TherapeuticsCompletedMetastatic MelanomaIsrael
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic Melanoma Naive to Immune Therapy in Metastatic SettingSwitzerland
-
Dana-Farber Cancer InstituteAstraZenecaWithdrawnUveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Recurrent Metastatic MelanomaUnited States
-
Pierre Fabre MedicamentRecruitingMetastatic Melanoma | Melanoma (Skin) | BRAF V600 MutationPortugal
-
TransMolecularTerminatedMelanoma | Metastatic Melanoma | Malignant MelanomaUnited States
-
Dermatologic Cooperative Oncology GroupRecruiting
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Centre Hospitalier Universitaire de NiceRecruitingMetastatic MelanomaFrance
-
Aivita Biomedical, Inc.Recruiting
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic MelanomaSwitzerland
-
Providence Health & ServicesPrometheus LaboratoriesActive, not recruitingMetastatic MelanomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingMetastatic MelanomaUnited States
-
The Netherlands Cancer InstituteCopenhagen University Hospital at HerlevActive, not recruitingMetastatic MelanomaNetherlands, Denmark
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruitingMetastatic MelanomaItaly, Germany, Spain, Greece, Austria, France, Poland, Sweden, Switzerland, United Kingdom
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLCTerminated
-
Iovance Biotherapeutics, Inc.Active, not recruitingMetastatic MelanomaUnited States, Spain, Germany, United Kingdom, France, Hungary, Italy, Switzerland
-
Novartis PharmaceuticalsTerminated
-
F. Stephen Hodi, MDMedImmune LLCCompletedMetastatic MelanomaUnited States
-
The Christie NHS Foundation TrustNational Institute for Health Research, United KingdomTerminatedMetastatic MelanomaUnited Kingdom
-
BiocadActive, not recruitingMelanoma | Melanoma MetastaticRussian Federation, Belarus
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer InstituteTerminated
-
CHU de ReimsCompletedMetastatic MelanomaFrance
-
Hospices Civils de LyonCompletedMetastatic MelanomaFrance
-
Nektar TherapeuticsImaginAb, Inc.Withdrawn
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer InstituteWithdrawnMetastatic MelanomaUnited States
-
BioNTech US Inc.Apexigen, Inc.TerminatedMetastatic MelanomaUnited States
-
Inge Marie SvaneCompleted
-
Nantes University HospitalUMR892Completed
-
University of RegensburgUnknown
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics...CompletedMetastatic MelanomaUnited States